Suchergebnisse - "Schild, Steven E"

PubPharm (29)

1

Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck

enthalten in: Anticancer research | 2023

von Zwaan, I. | Soror, T. | Bruchhage, K. | +3

2

Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer

enthalten in: Anticancer research | 2021

von Rades, D. | Narvaez, C. | Janssen, S. | +5

3

A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy : North Central Cancer Treatment Group (Alliance) N0923 Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2020

von Schenk, E. | Mandrekar, S. | Dy, G. | +11

CommentIn: Ann Transl Med. 2020 Sep;8(17):1113. - PMID 33145332

4

Concurrent Chemotherapy Improves the Overall Survival of Patients Irradiated for Locally Recurrent Bladder Cancer

enthalten in: Anticancer research | 2017

von Rades, D. | Manig, L. | Janssen, S. | +1

5

Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers

enthalten in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2017

von Rades, D. | Seidl, D. | Janssen, S. | +6

6

Radiochemotherapy for locally advanced squamous cell carcinoma of the head and neck : Higher-dose cisplatin every 3 weeks versus cisplatin/5-fluorouracil every 4 weeks

enthalten in: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery | 2016

von Rades, D. | Strojan, P. | Seidl, D. | +6

7

Chemoradiation of locally advanced squamous cell carcinoma of the head-and-neck (LASCCHN) : Is 20mg/m(2) cisplatin on five days every four weeks an alternative to 100mg/m(2) cisplatin every three weeks?

enthalten in: Oral oncology | 2016

von Rades, D. | Seidl, D. | Janssen, S. | +6

8

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers

enthalten in: BMC cancer | 2016

von Rades, D. | Seidl, D. | Janssen, S. | +4

9

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/$ m^{2} $ for definitive radiochemotherapy of locally advanced head-and-neck cancers

enthalten in: BMC cancer | 2016

von Rades, D. | Seidl, D. | Janssen, S. | +4

10

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/$ m^{2} $ for definitive radiochemotherapy of locally advanced head-and-neck cancers

enthalten in: BMC cancer | 2016

von Rades, D. | Seidl, D. | Janssen, S. | +4